Stephen Scarantino, MD
Obstetrics & Gynecology · Westbury, NYNPI 1316938921
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (48.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 73.4% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $9,209 and has fallen 85.7% since, to $1,316 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $73.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- AbbVie$602
- Sumitomo Pharma America, Inc.$498
- Aspira Women's Health Inc$349
- Celularity Inc.$300
- Mayne Pharma Commercial LLC$280
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$3002%
- Travel & lodging$3,52624%
- Food & beverage$3,82526%
- Education$7,24049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 37 | $10,932 |
| AbbVie(2 entities) | 32 | $602 |
| Sumitomo Pharma America, Inc. | 25 | $498 |
| Aspira Women's Health Inc | 6 | $349 |
| Celularity Inc. | 1 | $300 |
| Mayne Pharma Commercial LLC | 8 | $280 |
| Astellas Pharma US Inc | 10 | $211 |
| Shield Therapeutics Inc | 9 | $192 |
| Pfizer | 8 | $164 |
| Hologic Sales And Service, LLC | 4 | $161 |
| AMAG Pharmaceuticals, Inc. | 9 | $146 |
| Myovant Sciences Inc. | 10 | $139 |
| Novo Nordisk | 2 | $139 |
| Exeltis, USA Inc. | 6 | $123 |
| Agile Therapeutics, Inc. | 6 | $109 |
| Millicent US Inc | 6 | $95 |
| Coopersurgical, Inc. | 4 | $88 |
| Bayer | 4 | $87 |
| Lupin Inc. | 4 | $82 |
| Organon | 3 | $46 |
| Therapeuticsmd, Inc. | 3 | $45 |
| Evofem Biosciences, Inc. | 2 | $35 |
| Roche Diagnostics Corporation | 2 | $32 |
| Duchesnay USA Incorporated | 1 | $24 |
| Avion Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,000
- Da Vinci Surgical System$3,452
- Wegovy$119
- OVA1$107
How this compares
$14,891 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 115 | $11,091 |
| IntrarosaPrasterone (Dhea) | 12 | $5,641 |
| YuvafemEstradiol | 31 | $3,256 |
| ProgesteroneProgesterone, Micronized | 33 | $1,864 |
| Metronidazole | 86 | $1,337 |
| Clobetasol Propionate | 23 | $532 |
| Terconazole | 14 | $320 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $309 |
| Nystatin | 20 | $275 |
| ValacyclovirValacyclovir Hcl | 24 | $256 |
| Fluconazole | 78 | $216 |
| Triamcinolone Acetonide | 19 | $81 |
| Misoprostol | 11 | $58 |
| Amoxicillin | 25 | $58 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AMAG Pharmaceuticals, Inc.Intrarosa | $146 | $5,64112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Other obstetrics & gynecology in Westbury
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.